Correction of Glycogen Storage Disease Type II by Systemic Delivery of an AAV2/8 Vector Containing a Muscle-Specific Promoter

被引：0
|
作者：
Sun, Baodong [1 ]
Li, Ping [2 ]
Talmage, Brown [3 ]
Andrew, Bird [1 ]
Yan, Zhen [2 ]
Koeberl, Dwight D. [1 ]
机构：
[1] Duke Univ, Med Ctr, Div Med Genet, Durham, NC USA
[2] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
[3] N Carolina State Univ, Coll Vet Med, Raleigh, NC USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.636
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
563
引用
收藏
页码：S217 / S217
页数：1
相关论文
共 40 条
  • [21] DISCOVERY OF A LIVER-SPECIFIC ENHANCER-PROMOTER ELEMENT IN THE 3′UTR OF THE WILD-TYPE AAV2 GENOME PROVIDES NOVEL INSIGHTS INTO AAV VECTOR SAFETY IN THE HUMAN LIVER
    Logan, Grant J.
    Dane, Allison P.
    Hallwirth, Claus V.
    Smyth, Christine M.
    Wilkie, Emilie E.
    Amaya, Anais K.
    Zhu, Erhua
    Khandekar, Neeta
    Ginn, Samantha L.
    Liao, Sophia
    Cunningham, Sharon C.
    Sasaki, Natsuki
    Tam, Patrick P. L.
    Russell, David W.
    Lisowski, Leszek
    Alexander, Ian E.
    JOURNAL OF GENE MEDICINE, 2018, 20 (01):
  • [22] Long-Term Correction of Glycogen Storage Disease Type III by AAV-Mediated Gene Therapy Using a Dual Promoter to Express Bacterial Pullulanase
    Lim, Jeong-A
    Choi, Su Jin
    Kishnani, Priya S.
    Sun, Baodong
    MOLECULAR THERAPY, 2022, 30 (04) : 119 - 120
  • [23] Disease correction in mucopolysaccharidosis type IIIB mice by intraparenchymal or cisternal delivery of a capsid modified AAV8 codon-optimized NAGLU vector
    Rouse, Courtney J.
    Hawkins, Kimberley
    Kabbej, Nadia
    Dalugdug, Justin
    Kunta, Aishwarya
    Kim, Mi-Jung
    Someya, Shinichi
    Herbst, Zachary
    Gelb, Michael
    Dinelli, Isabella
    Butterworth, Elizabeth
    Falk, Darin J.
    Rosenkrantz, Erinn
    Elmohd, Hamza
    Khaledi, Hamid
    Mowafy, Samar
    Ashby, Frederick
    Heldermon, Coy D.
    HUMAN MOLECULAR GENETICS, 2023, 32 (03) : 417 - 430
  • [24] Single AAV Vector Gene Therapy with a Mini-GDE Transgene Corrects Muscle Impairment in Mouse, Rat and Human Cellular Models of Glycogen Storage Disease Type III
    Gardin, Antoine
    Rouillon, Jeremy
    Montalvo-Romeral, Valle
    Rossiaud, Lucille
    Vidal, Patrice
    Launay, Romain
    Vie, Mallaury
    Bertin, Berangere
    Dubreuil, Guillaume
    Nozi, Justine
    Jauze, Louisa
    Fragnoud, Romain
    Daniele, Nathalie
    Van Wittenberghe, Laetitia
    Esque, Jeremy
    Andre, Isabelle
    Nissan, Xavier
    Hoch, Lucile
    Ronzitti, Giuseppe
    MOLECULAR THERAPY, 2023, 31 (04) : 69 - 70
  • [25] Muscle-targeted gene therapy in glycogen storage disease type II with adeno-associated virus serotypes 7, 8, and 9
    Sun, Baodong
    Hauschka, Stephen
    Bird, Andrew
    Auten, Richard
    Koeberl, Divight
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S38 - S39
  • [26] Correction of Ventilation in Glycogen Storage Disease Type II Mice after Gel-Mediated Delivery of Adeno-Associated Virus Serotype 1 Vectors
    Mah, Cathryn
    DeRuisseau, Lara R.
    Pacak, Christina A.
    Lewis, Melissa A.
    Fuller, David D.
    Byrne, Barry J.
    MOLECULAR THERAPY, 2006, 13 : S221 - S222
  • [27] Administration of rAAV2/8 and rAAV2/1 Vectors Mediates Sustained Correction of a Canine Model of Glycogen Storage Disease Type Ia
    Correia, Catherine
    Weinstein, David
    Fiske, Laurie
    Verstegen, John
    Specht, Andrew
    Struck, Maggie
    Ramirez, Harvey
    Onclin-Verstegen, Karine
    Porvasnik, Stacy
    Chou, Janice
    Byrne, Barry
    Mah, Cathryn
    MOLECULAR THERAPY, 2009, 17 : S66 - S66
  • [28] AN OPEN LABEL PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA
    Weinstein, David A.
    Ahmad, Ayesha
    Poma, Allen
    Crombez, Eric
    MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 309 - 309
  • [29] AN OPEN LABEL PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA
    Weinstein, David A.
    Ahmad, Ayesha
    Poma, Allen
    Crombez, Eric
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 333 - 333
  • [30] Positive Cohort 1 Results from the Phase 1/2 Trial with AAV8-Mediated Liver-Directed Gene Therapy in Adults with Glycogen Storage Disease Type Ia
    Weinstein, David A.
    Ahmad, Ayesha
    Lee, Connie
    Poma, Allen
    Crombez, Eric
    MOLECULAR THERAPY, 2019, 27 (04) : 12 - 12
1234